Evofem Biosciences, Inc. Annual Nonoperating Income (Expense) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Evofem Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2023.
  • Evofem Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $2.75M.
  • Evofem Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $71.6M, a 36% decline year-over-year.
  • Evofem Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $70.8M, a 848% increase from 2022.
  • Evofem Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $7.47M.
  • Evofem Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was -$38.4M, a 0.79% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $70.8M +$63.4M +848% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $7.47M +$45.8M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 -$38.4M +$307K +0.79% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-27
2020 -$38.7M -$11.4M -41.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 -$27.3M +$20.8M +43.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 -$48.1M +$21.5M +31% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$69.6M -$35.9M -106% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-01
2016 -$33.7M Jan 1, 2016 Dec 31, 2016 8-K/A 2018-04-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.